Key result
Letter addresses CYP2C19 genetic variants and outcomes in Arab patients undergoing PCI.
Key points are not available for this paper at this time.
Design
Letter
Answers are grounded in this paper and cite their sources.
No actionable evidence for CYP2C19 testing in Arab PCI patients; leaves open need for dedicated population studies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Saiz‐Rodríguez et al. (2023) reported a letter. This document is a letter to the editor regarding the effect of CYP2C19 genetic variants on outcomes in Arab patients undergoing PCI, and contains no primary study data.
Synapse has enriched 10 related papers. Consider them for comparative context: